TOBAM’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.51M Buy
44,932
+1,195
+3% +$93.5K 1.37% 30
2025
Q1
$3.17M Sell
43,737
-15,557
-26% -$1.13M 1.35% 22
2024
Q4
$4.39M Sell
59,294
-16,353
-22% -$1.21M 1.34% 25
2024
Q3
$4.99M Buy
75,647
+72,999
+2,757% +$4.82M 0.91% 43
2024
Q2
$245K Sell
2,648
-1,536
-37% -$142K 0.04% 170
2024
Q1
$400K Buy
4,184
+1,108
+36% +$106K 0.04% 162
2023
Q4
$235K Sell
3,076
-1,223
-28% -$93.4K 0.02% 206
2023
Q3
$298K Sell
4,299
-551
-11% -$38.2K 0.02% 164
2023
Q2
$458K Sell
4,850
-1,512
-24% -$143K 0.03% 148
2023
Q1
$526K Buy
6,362
+647
+11% +$53.5K 0.03% 142
2022
Q4
$426K Buy
5,715
+2,979
+109% +$222K 0.03% 150
2022
Q3
$226K Sell
2,736
-343
-11% -$28.3K 0.02% 203
2022
Q2
$293K Buy
3,079
+842
+38% +$80.1K 0.02% 207
2022
Q1
$263K Buy
2,237
+121
+6% +$14.2K 0.01% 213
2021
Q4
$274K Hold
2,116
0.01% 177
2021
Q3
$240K Hold
2,116
0.01% 179
2021
Q2
$219K Hold
2,116
0.01% 193
2021
Q1
$177K Hold
2,116
0.01% 199
2020
Q4
$193K Hold
2,116
0.01% 192
2020
Q3
$169K Buy
+2,116
New +$169K 0.01% 180
2017
Q3
Sell
-8,124
Closed -$320K 144
2017
Q2
$320K Buy
+8,124
New +$320K 0.01% 129
2015
Q4
Sell
-906,762
Closed -$21.5M 120
2015
Q3
$21.5M Sell
906,762
-1,151,706
-56% -$27.3M 0.84% 43
2015
Q2
$48.9M Sell
2,058,468
-1,566,144
-43% -$37.2M 1.78% 21
2015
Q1
$86.1M Sell
3,624,612
-60,156
-2% -$1.43M 2.62% 10
2014
Q4
$78.2M Sell
3,684,768
-1,474,104
-29% -$31.3M 2.59% 8
2014
Q3
$87.8M Buy
5,158,872
+1,777,116
+53% +$30.3M 2.48% 9
2014
Q2
$48.4M Sell
3,381,756
-1,608,336
-32% -$23M 2.14% 14
2014
Q1
$61.7M Sell
4,990,092
-688,296
-12% -$8.51M 3.07% 7
2013
Q4
$62.2M Buy
5,678,388
+1,444,758
+34% +$15.8M 3.19% 6
2013
Q3
$49.1M Buy
4,233,630
+815,604
+24% +$9.47M 2.75% 11
2013
Q2
$38.3M Buy
+3,418,026
New +$38.3M 2.51% 13